Pharma gets a reprieve amid tariffs but not for long
- President Trump announced tariffs on April 2, with the event at 9pm Irish time.
- The administration believes some countries engage in unfair trade practices, leading to the tariffs.
- The announcement clarified some goods, like pharmaceuticals and semiconductors, would be exempt.
- Danny McCoy stated the tariffs will create a net export impact of around 2-3% short-term.
- The EU announced countermeasures, but Ursula Von der Leyen wants negotiation over confrontation.
13 Articles
13 Articles
Trump Spares Semiconductors in Latest Tariffs, but Risks Mount for Chinese Chipmakers
Trump Spares Semiconductors in Latest Tariffs, but Risks Mount for Chinese Chipmakers - Despite temporary relief, companies in China face uncertainty as Washington may try tougher measures on components embedded in U.S.-bound goods
Pharmaceuticals, semiconductors escape US tariffs – for now
Ireland’s pharmaceutical and semiconductor exports are exempt under last night’s US tariffs announcement, but it remains to be seen if these will be hit with subsequent regulations or tariffs. Read more: Pharmaceuticals, semiconductors escape US tariffs – for now
Bayer exec urges EU to avoid trade war as pharma dodges tariffs (for now)
Bayer’s head of Pharmaceuticals talks to Euractiv about US tariffs, expresses scepticism over CMA, and how the discussion on RDP should be focused on increasing it for incentivising competitiveness.
Coverage Details
Bias Distribution
- 50% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage